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ABstrAct
Objectives: To examine cases applied with caesarean hysterectomy because of placenta percreta by comparing changes 
in treatment strategies and complications according to year. 
Material and methods: A retrospective examination was made of 93 patients applied with caesarean hysterectomy with 
a diagnosis of placenta percreta in 5-year periods of 2005–2009, 2010–2014, and 2015–2019. Demographic characteristics 
were recorded, and previous caesareans, history of myomectomy and curettage, gestational weeks, and infant birthweight. 
Intraoperative and postoperative findings were recorded as operating time, length of stay in hospital and Intensive Care Unit 
(ICU), transfusion requirement, the amount of erythrocyte suspension (ES) and fresh frozen plasma (FFP) transfused, and re-
quirement for massive transfusion. Anaesthesia type, complications, and the preferred skin-uterus incision were also recorded.  
results: The 93 patients comprised 8 cases in the period 2005–2009, 23 in 2010–2014, and 62 in 2015–2019. The number 
of previous caesarean procedures was observed to increase in parallel with these case numbers. A significant increase was 
observed in the gestational week of birth, and infant birthweight, and a decrease in operating times. In later years there was 
seen to be a lower amount of ES and FFP transfused and fewer patients with massive transfusion. Preoperative diagnosis 
of placenta percreta, the highest preference for general anaesthesia, selection of midline vertical skin incision and uterine 
fundal incision were greatest in the period 2015–2019. 
conclusions: In cases with placenta percreta, of which there is an increasing incidence, maternal and infant outcomes 
can be optimised with prenatal diagnosis and planned caesarean hysterectomy by a multidisciplinary team with optimal 
prenatal preparation.
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IntrOdUctIOn
Placenta accreta spectrum (PAS) describes a disease spec-
trum in which there is abnormal adherence of trophoblasts to 
the placenta. In 79% of cases the most mild form of placenta 
accreta is seen, in 14%, placenta increta, and in 7%, placenta 
percreta is formed with the most morbidity and mortality. 
While there is superficial myometrial invasion in placenta ac-
creta, there is deep myometrial invasion in placenta increta, 
and in cases of placenta percreta, the myometrial invasion 
reaching the uterus serosa reaches as far as surrounding tissue 
and organs. The greatest clinical problem is massive bleeding 
when attempting to remove the placenta from the uterus after 
delivery of the fetus [1, 2]. Even if the procedure is switched 
to hysterectomy, this intense bleeding can lead to multi-or-
gan failure disseminated intrvascular coagulation and even 
death. Surviving cases, especially those with complications 
related to urinary system damage, require ICU admittance and 
transfusion-related complications may be seen [2, 3]. 
PAS occurs due to placental trophoblasts not attaching 
to scarred myometrium in the absence of a decidua basalis 
in a normal structure to which they would adhere secondary 
to endometrium damage [4]. The most common reasons 
for this endometrium damage are uterine surgery such as 
primarily caesarean procedures and myomectomy, and en-
dometrial ablation applied by the cervical route, curettage 
and uterine artery embolisation [5]. 
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As more caesarean deliveries are performed, there has 
been a rapid increase over the years in the incidence of PAS. The 
incidence was first reported in 1937 by Irving and Hertig as 1 in 
30,000 births, and this rate has now risen to 1 in 533 births [6, 7]. 
Significant changes have occurred in the 50-year process 
of the diagnosis and management of PAS cases. A fundamental 
change came in diagnosis of the disease with the use of ultra-
sonography in the preoperative period in the 1980s [8–10]. 
Just as preoperative diagnosis allows the referral of patients 
to specialised centres and the opportunity to be operated on 
under elective conditions, it is also useful in respect of obtaining 
the opinions of assistive branches such as interventional radiol-
ogy, general surgery and urology. Moreover, identification of 
the disease in the preoperative period allows several surgical 
modifications to be made, ranging from modifications to the 
skin and uterus incisions to uterus-sparing procedures [1, 9, 10].
Objectives
The aim of this study was to examine cases applied with 
caesarean hysterectomy because of placenta percreta in our 
tertiary level clinic in the last 15 years by comparing changes 
in treatment strategies and complications according to year, 
and discussing these in the light of the relevant literature.  
MAtHErIAL And MEtHOds
A retrospective examination was made of 125 patients 
applied with peripartum hysterectomy because of PAS in 
our university clinic between January 2005 and December 
2019. From these cases, the study included 93 patients who 
were > 24 gestational weeks with the diagnosis of placenta 
percreta confirmed histopathologically, and with all data 
available. This study conforms with the principles of the 
2008 Declaration of Helsinki and was approved by the Local 
Ethics Committee of our university.
A record was made for each case of demographic char-
acteristics, previous caesareans, history of myomectomy 
and curettage, gestational weeks, and infant birthweight. 
Intraoperative and postoperative findings were recorded 
as operating time, rates and length of stay in the Intensive 
Care Unit (ICU), total length of stay in hospital, the need 
for transfusion, the amount of erythrocyte suspension (ES) 
and fresh frozen plasma (FFP) transfused, and rates of the 
requirement for massive transfusion. The type of anesthesia, 
complications of damage to adjacent organs, and the pre-
ferred skin-uterus incision were also recorded. To investigate 
the change in approaches and outcomes of the patients, all 
the cases were separated into 5-year periods of 2005–2009, 
2010–2014, and 2015–2019. 
statistical Analysis
Data obtained in the study were analysed statistically 
using the Statistical Package for the Social Sciences vn. 
21.0 software (SPSS, Armonk, New York, IL, USA). Con-
formity of continuous data to normal distribution was 
assessed with the Kolmogorov-Smirnov test. Quantitative 
variables were stated as mean±standard deviation (SD) 
and median range (minimum-maximum) values. Multi-
ple group comparisons were made with ANOVA and the 
Tukey HSD test. Categorical data were stated as number 
(n) and percentage (%). A value of p < 0.05 was accepted 
as statistically significant.
rEsULts
The 93 patients comprised 8 cases in the period 2005–
2009, 23 cases in 2010–2014, and 62 cases in 2015–2019. The 
increase in the number of cases was determined to be sta-
tistically significant (p < 0.004) (Fig. 1). 
No statistically significant difference was determined 
between the groups in respect of patient age, BMI, grav-
ida, parity, and history of myomectomy and curettage 
(p > 0.05 for all) (Tab. 1). The number of previous caesar-
ean procedures was mean 1.74 ± 1.00 for the period of 
2005–2009, 2.15 ± 0.95 for 2010–2014, and 2.79 ± 1.03 for 
2015–2019, and the increase was determined to be statisti-
cally significant (p = 0.012).  
In the examination of the intra-operative and postopera-
tive findings, there was observed to be a statistically signifi-
cant increase in the gestational week at which patients gave 
birth and a parallel increase in infant birthweight (p = 0.026, 
p = 0.035). When the operating times were compared, there 
was seen to be a statistically significant decrease in the times 
over the years (p = 0.004). No statistically significant differ-
ence was observed between the groups in respect of the 
rates of adult ICU admittance and the length of stay in ICU 
(p = 0.157, p = 0.519). The total length of hospital stay was 
found to be statistically significantly shorter in the period 
2015–2019 compared to the earlier years (p = 0.026). No 
statistically significant difference was seen according to 
the years in respect of patients requiring transfusion and 
hypogastric artery ligation (p = 0.215, p = 0.349, respec-
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Figure 1. Number of cases by years
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be a statistically significantly lower amount of ES and FFP 
transfused and fewer patients applied with massive transfu-
sion (p = 0.039, p = 0.041, p = 0.016, respectively) (Tab. 2).
When all the cases were examined, the rate of preop-
erative diagnosis of placenta percreta was determined to 
be statistically significantly highest in the period 2015–
2019 (p = 0.001). 
The preference for general anaesthesia was determined 
to be statistically significantly higher in 2015-2019 com-
pared to the other periods (p = 0.021). No difference was 
seen between the 5-year periods in respect of perioperative 
complications (p = 0.458). In the comparison of the change 
in skin and uterus incisions over the years, the preference of 
skin incision was observed to change from Pfannenstiel to 
midline vertical, and in parallel with this, there was a signifi-
cant change in uterine incision from Kerr incision to fundal 
incision (p = 0.001) (Tab. 3). 
dIscUssIOn
For patients with a diagnosis of placenta percreta, cae-
sarean hysterectomy is the current standard treatment, in 
which the infant is delivered  far from the placenta (usually 
from the fundus) under elective conditions at an appropriate 
gestational week before the onset of labour and bleeding, 
and the uterine incision is closed without touching the 
placenta [11]. Cases with a confirmed preoperative diag-
nosis of placenta percreta in our clinic are applied with 
caesarean hysterectomy as standard. 
In recent years, there has been an increasing trend in 
cases applied with caesarean hysterectomy because of 
placenta percreta in our clinic, and throughout the world 
[12]. The most common risk factor for placenta accreta is 
a history of caesarean delivery. A systematic review showed 
that this rate reached 50–67% in patients with placenta 
previa and a history of at least 3 caesarean deliveries [13]. 
In the current series, there was a noticeable increase in the 
history of caesarean deliveries according to the years. 
The increasing rate of caesareans throughout the world in the 
last few decades is the primary reason for the increase in 
the incidence of placenta percreta [1]. 
An interesting finding in the current series was that as 
the years progressed, there was an increase in the gesta-
tional week at which the infant was delivered and in paral-
lel, an increase in infant birthweight. It was noteworthy 
that in the last 10 years, the cases were operated on at 
34–35 weeks. When determining the optimal time of de-
table 1. Demographic characteristics of the cases
2005–2009 (n = 8) 2010–2014 (n = 23) 2015–2019 (n = 62) p value
Age [years] 33.20 ± 4.54 32.69 ± 3.62 34.24 ± 4.31 0.303
BMI [kg/m2] 25.87 ± 2.30 26.34 ± 2.72 26.47 ± 3.29 0.468
Gravida 4.33 ± 1.86 4.40 ± 1.81 4.64 ± 0.99 0.756
Parity 3.40 ± 0.89 2.50 ± 1.29 2.85 ± 0.78 0.245















Data are stated as mean ± standard deviation or number (n) and percentage (%). Significant p values are shown in bold and italics; BMI — body mass ındex
table 2. Intra-operative and postoperative findings of the cases











Operating time [mins] 128.05 ± 36.48 110.54 ± 32.41 89.66 ± 27.23 0.004
Length of stay in adult ICU [days] 2.38 ± 2.14 2.50 ± 1.54 2.72 ± 2.02 0.519
Total length of hospital stay [days] 6.53 ± 3.12 5.02 ± 2.56 4.54 ± 1.43 0.026
Transfusion requirement (n/%) 7 (87.5%) 20 (86.9%) 50 (80.6%) 0.215
Transfused ES [units] 6.52 ± 2.94 5.94 ± 1.82 4.31 ± 1.91 0.039
Transfused FFP [units] 3.36 ± 2.12 2.00 ± 1.30 2.09 ± 0.83 0.041
Massive transfusion requirement (n/%) 6 (87.5%) 17 (73.9%) 19 (30.6%) 0.016
Hypogastric artery ligation  (n/%) 2 (25%) 5 (21.7%) 12 (19.6%) 0.349
Data are stated as mean ± standard deviation or number (n) and percentage (%). Significant p values are shown in bold and italics; ICU — intensive care unit;  
ES — erythrocyte suspension; FFP — fresh frozen plasma
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livery for these elective cases, both maternal and infant 
well-being must be taken into consideration, but there is 
no consensus as yet on this subject. The infrastucture of the 
neonatal ICU (NICU) and experience with pre-term infants 
at the hospital where the birth is to take place must also be 
considered. The success rates of most NICUs with newborns 
born after 34 gestational weeks are  high. There is known 
to be an increased risk of maternal bleeding after the 36th 
gestational week [14]. Therefore, the optimal birthweek is 
recommended by the American College of Obstetricians 
and Gynecologists (ACOG) as 34+0–356/7 [15] and by the 
Royal College of Obstetricians and Gynaecologists (RCOG) 
as 35+0–36+6 [16].
Another interesting point of the current study was that 
lower amounts of blood products were transfused to pa-
tients in more recent years. In parallel, there was observed 
to be an increase in the rate of patients operated on with 
a preoperative diagnosis and shorter operating times. 
As the total amount of blood loss may be less in surgery 
under elective conditions compared to patients who start 
vaginal bleeding in the antenatal period and are operated 
on after losing blood from the vaginal route, there could 
therefore be less requirement for transfusion. However, an-
other reason for shorter operating times and less bleeding 
could be that the operations of these types of cases under 
elective conditions are performed by more experienced 
surgeons. Therefore, a prenatal diagnosis is very important 
for these cases, so that surgery can be applied under elective 
conditions, and patients can be referred to centres where 
there are more experienced surgeons and a multidisciplinary 
approach is possible (obstetric surgeons, anaesthesiologists, 
neonatologists, interventional radiologists, blood bank and 
nursing personnel experienced in this subject) [17]. 
The preference of anaesthesia type for these cases was 
seen to have shifted over the years from regional anaesthe-
sia towards general anaesthesia. This can be considered to 
be due to the increasing rate of diagnosis, because in cae-
sarean cases where an unpredicted hysterectomy is made 
using a Pfannenstiel incision with no abnormal bleeding risk, 
the first choice is regional anaesthesia for reasons such as 
better postoperative pain relief, fewer adverse effects and 
more rapid recovery. However, in placenta percreta cases 
with a complex procedure applied with a large midline inci-
sion, where there is a greater possibility of more bleeding, 
hypovolemia and hemodynamic instabiity, the preferred 
anaesthesia method is general anaesthesia with a controlled 
airway [18]. In cases with suspected placenta percreta where 
a definitive diagnosis is needed intraoperatively, epidural 
anaesthesia can be applied as it can be later converted to 
general anaesthesia to be able to perform a hysterectomy. 
The incision preferences were seen to have changed in 
recent years to a midline vertical abdominal incision and 
a fundal uterus incision. This is because in these patients 
diagnosed preoperatively with placenta percreta, the deci-
table 3. The rates of prenatal diagnosis, type of anaesthesia, incisions and complications of all the cases
2005–2009 (n = 8) 2010–2014 (n = 23) 2015–2019 (n = 62) p value
Prenatal diagnosis of Placenta percreta 0.001
Yes 1 8 55
No 7 15 7
type of Anaesthesia 0.021
General 4 13 59
Regional 4 10 3
Perioperative surgical complications 0.458
Bladder damage 2 4 15
Ureter damage 0 1 1
Intestine damage 0 0 0
skin incision 0.013
Pfannenstiel 8 10 10
Midline vertical 0 13 52
Uterine incision 0.001
Kerr 7 10 0
Low vertical 1 0 10
High vertical 0 3 2
Fundal 0 10 50
Data are stated as mean ±standard deviation or number (n) and percentage (%). Significant p values are shown in bold and italics
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sion to perform hysterectomy has been made definitely 
before the operation. Although there are case series show-
ing good results obtained with transverse incisions such as 
Pfannenstiel, Maylard and Cherney [19], when performing 
a hysterectomy in a large pregnant patient, it can be consid-
ered necessary to use a midline vertical incision to provide 
sufficient visualisation and to easily reach the uterus and the 
retroperitoneal large vessels. Another advantage of midline 
vertical incision is that it provides easy access to the uterine 
fundus when the infant has to be delivered far from the part 
of the uterus where the placenta has settled and in most 
cases this region is the uterus fundal section [11]. 
No significant difference was observed between the 
cases in this series in respect of complication rates. 
The majority of intraoperative complications are urinary 
system complications, most of which are bladder perfo-
rations at an incidence of up to 17% [20]. When there is 
placental invasion of the bladder and in the presence of 
very dense bladder adhesions, bladder complications are 
inevitable. Prenatal diagnosis and differences in incision 
type and the surgeon’s experience can be considered not 
to have changed the rates of bladder complications. 
There were some limitations to this study, primarily that 
when analysing the cases they were examined in 3 groups of 
5-year periods. However, in the early years there were very 
few cases, and in more recent years there were many more 
cases. Therefore, to be able to statistically analyse the cases it 
was necessary to group them in this way. Another limitation 
could be considered to be that there were no follow-up data 
of the newborn infants of the cases. 
cOncLUsIOns
There is an increasing incidence of placenta accreta, for 
which the primary risk factors are a history of caesarean de-
livery and placenta previa. A prenatal diagnosis can reduce 
morbidity and mortality. Ultrasound is the best imaging 
modality in prenatal diagnosis. The timing of the birth 
should be planned on an individual basis but is generally 
at 34–36 weeks. The standard treatment for placenta accreta 
is planned caesarean and hysterectomy. Maternal and infant 
outcomes can be optimised with a multidisciplinary team 
and optimal prenatal preparation.
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